Researchers Discover Potential Anti-Aging Effects of Psilocybin from Psychedelic Mushrooms

New research indicates that psilocybin from psychedelic mushrooms may have anti-aging properties, extending cellular and organismal lifespan and improving health markers in aged models.
Recent research from Baylor College of Medicine suggests that psilocybin, the active compound found in psychedelic mushrooms, may possess remarkable anti-aging properties. In a study published in the journal npj Aging, scientists demonstrated that psilocybin can extend both cellular and organismal lifespans. The investigation revealed that psilocybin reduces several markers of aging at the cellular level, including delaying cellular senescence, preserving telomere length, and diminishing oxidative stress. Notably, the active metabolite of psilocybin, psilocin, was shown to significantly extend the lifespan of human lung fibroblast cells by up to 57% depending on dosage. It also increased the expression of SIRT1, a gene linked to longevity, and improved critical cellular DNA damage responses.
Furthermore, when administered to aged mice equivalent to 60-year-old humans, psilocybin improved survival rates and enhanced physical features like fur quality, indicative of healthier aging. This suggests that psilocybin could be a powerful agent for promoting healthy aging, even when introduced later in life. Lead researcher Dr. Kosuke Kato emphasized that these findings open new avenues for psychedelic research, extending beyond psychological benefits, to potential anti-aging therapies.
While these promising results highlight psilocybin's potential to slow the aging process, experts caution that further research, particularly human clinical trials, is necessary to determine optimal dosing, safety, and long-term effects. If validated, psilocybin therapy may become a novel approach to combating age-related diseases and enhancing quality of life during aging. The study underscores the importance of exploring the systemic benefits of psychedelics beyond their neurological and psychiatric applications.
Stay Updated with Mia's Feed
Get the latest health & wellness insights delivered straight to your inbox.
Related Articles
Could a Mini-Stroke Lead to Persistent Fatigue?
Research shows that mini-strokes can lead to persistent fatigue lasting up to a year, emphasizing the importance of long-term monitoring and care.
Understanding Post-Intensive Care Syndrome and Its Long-Term Impact
Research reveals that over half of ICU survivors experience lasting cognitive, physical, and psychological impairments, with key risk factors aiding early detection and intervention efforts.
Increasing Staff Levels in Aged Care: Does More Staffing Improve Care Quality?
While increased staffing levels in aged care homes meet targets, recent research questions whether it truly improves care quality. A nuanced approach focusing on workforce skills and support is crucial for better outcomes.